These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 629246)
1. Measles revaccination. Persistence and degree of antibody titer by type of immune response. Deseda-Tous J; Cherry JD; Spencer MJ; Welliver RC; Boyer KM; Dudley JP; Zahradnik JM; Krause PJ; Walbergh EW Am J Dis Child; 1978 Mar; 132(3):287-90. PubMed ID: 629246 [TBL] [Abstract][Full Text] [Related]
2. Booster vaccination with further live attenuated measles vaccine. Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997 [TBL] [Abstract][Full Text] [Related]
3. Measles immunity and response to revaccination among secondary school children in Cumbria. Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005 [TBL] [Abstract][Full Text] [Related]
4. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581 [TBL] [Abstract][Full Text] [Related]
5. Need for measles revaccination in adolescents: correlation with birth date prior to 1972. Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921 [TBL] [Abstract][Full Text] [Related]
6. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602 [TBL] [Abstract][Full Text] [Related]
7. Impact of revaccinating children who initially received measles vaccine before 10 months of age. Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615 [TBL] [Abstract][Full Text] [Related]
8. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels]. Sokhin AA; Sliusar' LI; Popov VF; Noskov FS; Radomskaia FS Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):79-85. PubMed ID: 6637278 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies. Cutts FT; Bartoloni A; Guglielmetti P; Gil F; Brown D; Bianchi Bandinelli ML; Roselli M Trans R Soc Trop Med Hyg; 1995; 89(1):119-22. PubMed ID: 7747295 [TBL] [Abstract][Full Text] [Related]
10. Measles immunization. Successes and failures. Yeager AS; Davis JH; Ross LA; Harvey B JAMA; 1977 Jan; 237(4):347-51. PubMed ID: 576165 [TBL] [Abstract][Full Text] [Related]
11. Measles immunity and response to revaccination of a young adult population in Israel. Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290 [TBL] [Abstract][Full Text] [Related]
12. Immune status following measles vaccination in infants and evaluation for the need of revaccination. Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977 [TBL] [Abstract][Full Text] [Related]
14. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus. Aleksandrowicz J; Polna I; Sadowski W Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633 [No Abstract] [Full Text] [Related]
15. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines. Whittle H; Aaby P; Samb B; Cissé B; Kanteh F; Soumaré M; Jensen H; Bennett J; Simondon F Pediatr Infect Dis J; 1999 Jan; 18(1):53-7. PubMed ID: 9951981 [TBL] [Abstract][Full Text] [Related]
16. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity]. Saika S; Matsunaga T; Ogawa T; Ichinohe S Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482 [TBL] [Abstract][Full Text] [Related]
17. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946 [TBL] [Abstract][Full Text] [Related]
18. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response. Isa MB; Martínez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria. Onoja AB; Adeniji AJ Int J Infect Dis; 2013 Jul; 17(7):e552-5. PubMed ID: 23510540 [TBL] [Abstract][Full Text] [Related]
20. [Unsuitability of children revaccination against measles]. Bolotovskiĭ VM; Titova NS Sov Med; 1981; (9):43-8. PubMed ID: 7313794 [No Abstract] [Full Text] [Related] [Next] [New Search]